天津医药
核因子κB抑制剂与多烯紫杉醇联合治疗未分化甲状腺癌的体内研究
张富海1 ,孟召伟2 ,谭建2
Combination of NF-κB Inhibitor and Docetaxel Enhances Anti-tumor Activity in Anaplastic Thyroid Cancer Cell Xenograft in Vivo
天津医药 . 2010, (8): 0 -0 .